Article
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
The Journal of allergy and clinical immunology - 1 Mar 2001
Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T
Abstract excerpt
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease in which antigen-presenting epidermal dendritic cells (DCs), ie, Langerhans cells and the so-called inflammatory dendritic epidermal cells (IDECs) expressing the high-affinity receptor for IgE (FcepsilonRI) may play a significant pathophysiologic role. Therapeutic efficacy of the immunosuppressive macrolide tacrolimus (FK506) in AD has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
